Antibiotic duration and changes in FEV1 are not associated with time until next exacerbation in adult cystic fibrosis: a single center study

Abstract Background Pulmonary exacerbations (PEx) are a major driver of morbidity and mortality in cystic fibrosis and reducing their frequency by extending the time between them is an important therapeutic goal. Although treatment decisions for exacerbations are often made based on dynamic changes...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Julia C. Espel, Hannah L. Palac, Joanne F. Cullina, Alexandria P. Clarke, Susanna A. McColley, Michelle H. Prickett, Manu Jain
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2017-11-01
Edice:BMC Pulmonary Medicine
Témata:
Antibiotics
Bronchiectasis
Cystic fibrosis
Exacerbation
Outcomes Pseudomonas aeruginosa
On-line přístup:http://link.springer.com/article/10.1186/s12890-017-0503-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky